NIDA Consortium on Diversity Affairs
About NIDA
- 2010 Strategic Plan
- Organization
- Offices
- Office of the NIDA Director (OD)
- Director's Page
- AIDS Research Program (ARP)
- International Program (IP)
- Intramural Research Program (IRP)
- Special Populations Office (SPO)
- Related Funding Opportunities
- NIDA SPO Research Programs
- Research Training Opportunities
- African American Researchers and Scholars Work Group (AARSWG)
- Asian American Pacific Islander Researchers and Scholars Workgroup (AAPI)
- National Hispanic Science Network
- American Indian/Alaska Native Researchers and Scholars Workgroup (AIANRSWG)
- American Indian/Alaska Native (AI/AN) Coordinating Committee
- Staff Listing
- LPC Staff
- SPO/Lead Program Coordinating (LPC) Task Force
- FAQs About: Research Supplements to Promote Diversity in Health-Related Research (Diversity Supplements)
- Instructions to Principal Investigators Applying for Research Supplements to Promote Diversity in Health-Related Research
- NIDA Consortium on Diversity Affairs
- Health Disparities
- Women & Sex/Gender Differences Research Program
- Office of Management (OM)
- Office of Extramural Affairs (OEA)
- Office of Science Policy and Communications (OSPC)
- Office of the NIDA Director (OD)
- CCTN
- Divisions
- Workgroups, Interest Groups and Consortia
- Offices
- Director's Page
- Legislative Activities
- Advisory Boards & Groups
- Employment Opportunities
- Donating to NIDA
- Contact Us
- Other Resources
This Consortium serves as the review committee for the Diversity Supplement Program. Below is a list of the current members.
Name | Area(s) of Expertise | Phone |
---|---|---|
Pamela Goodlow (Chair) |
Ethnic/minority issues, research training and career development |
301-435-0925 |
Drug abuse treatment research, treatment research in community settings, treatment of pain |
301-443-3207 |
|
Ethnic populations (Hispanic/Latino and Asian American and Pacific Islander) |
301-443-0441 |
|
Grant management issues |
202-722-4093 |
|
Pharmacology; neuroscience; AIDS |
301-402-1972 |
|
Neuroplasticity and neurotoxicology; methamphetamine; marijuana; hallucinogens |
301-435-1312 |
|
Treatment and Intervention Services for HIV/AIDS; gender differences; co-occurring disorders |
301-402-1984 |
|
Medical consequences of drug abuse and co-occurring infections; clinical molecular biology; immunology; neuroscience |
301-443-1061 |
|
Prenatal/perinatal exposure; maternal/fetal pharmacokinetics; pain/analgesia; physiological systems |
301-594-5753 |
|
Prevention; early interventions; preadolescent and adolescent drug abuse and HIV prevention; methodology research |
301-402-1533 |
|
Grants management issues |
410-254-1853 |
This page was last updated April 30, 2012.
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.